Goldman Sachs Downgrades Health Net (HNT) to Neutral; California Issues Could Weigh
Tweet
Share
E-mailGet Alerts HNT Hot Sheet
Price: $67.19 --0%
Rating Summary:
4 Buy, 11 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
4 Buy, 11 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Goldman Sachs downgraded Health Net (NYSE: HNT) from Buy to Neutral with a price target of $29 (down from $32).
The firm said the regulatory and pricing environment in core market California is increasingly less favorable in comparison with other markets. This will likely limit upside to 2012-2013 and may make a possible acquisition of the company somewhat less likely.
For more ratings news on Health Net click here and for the rating history of Health Net click here.
Shares of Health Net closed at $26.61 yesterday.
The firm said the regulatory and pricing environment in core market California is increasingly less favorable in comparison with other markets. This will likely limit upside to 2012-2013 and may make a possible acquisition of the company somewhat less likely.
For more ratings news on Health Net click here and for the rating history of Health Net click here.
Shares of Health Net closed at $26.61 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Shanghai Jahwa United (600315:CH) to Neutral
- DZ Bank Downgrades Frontline Ltd. (FRO) to Sell
- TD Cowen Downgrades Roots Corp. (ROOT:CN) (RROTF) to Sell
Create E-mail Alert Related Categories
Downgrades, RumorsRelated Entities
Goldman SachsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
